Advanced Search

 

Study ID Status Title Patient Level Data
200111 Completed A Retrospective Medical Records Review of patients receiving pazopanib therapy for advanced RCC at the Christie Hospital
200115 Completed Bioequivalence Study for an Isotretinoin Pharmaceutical Preparation - capsules. Open, crossover, randomized, single dose, three treatments, three periods and six sequences with meal (breakfast) study
200116 Completed SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF EFFICACY AND SAFETY/TOLERABILITY OF 3RD AGENT ANTIRETROVIRAL TREATMENTS IN ANTIRETROVIRAL-NAÏVE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 POSITIVE PATIENTS
200137 Not yet recruiting A Phase 4, Open-label Field Study (200137) to Evaluate the Clinical Benefit, Safety and Pharmacokinetics in Subjects treated with Raxibacumab (GSK3068483) Following Exposure to Bacillus anthracis
200142 Completed Study of barriers to adherence using the Adherence Starts with Knowledge 20 (ASK-20) in adult asthma patients receiving treatment with inhaled corticosteroid-containing drug products
200146 Withdrawn Evaluation of Patient Tolerability Associated with Vemurafenib Treatment of Advanced or Metastatic Melanoma
200147 Completed Safety and immunogenicity study of 2 formulations of GSK Biologicals’ varicella vaccines given as a 2-dose course in the second year of life.
200149 Active, not recruiting A Randomized, Multi-Center, Blinded, Placebo-Controlled Study Of Mapatumumab ([HGS1012], A Fully Monoclonal Antibody To TRAIL-R1) In Combination With Sorafenib As A First-Line Therapy In Subjects With Advanced Hepatocellular Carcinoma Study Listed on ClinicalStudyDataRequest.com
200150 Active, not recruiting A prospective, epidemiological study to assess the disease burden of RSV associated, suspected LRTIs from 0 to 2 years and population attributable risk percent of RSV LRTI on the development of recurrent wheeze and asthma from 0 to 6 years
200157 Completed An observer-blind study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ investigational vaccine GSK2838504A when administered to Chronic Obstructive Pulmonary Disease (COPD) patients
200158 Completed Risk factors associated with pertussis among infants less than one-year of age
200160 Completed Study for evaluation of immunogenicity and reactogenicity of Fluarix/Influsplit SSW 2013/2014 in people 18 years of age and above
200163 Completed A Two Part, Phase IIa, Randomized, Placebo-controlled Study To Investigate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin (GSK1325756) in Symptomatic COPD Subjects with Mild to Moderate Airflow Limitation at Risk for Exacerbations
200165 Completed Study 200165, A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Compare the Efficacy of a 2-Week Treatment with Fluticasone Propionate Nasal Spray versus Cetirizine in Adult Subjects with Seasonal Allergic Rhinitis (SAR) Study Listed on ClinicalStudyDataRequest.com
200167 Active, Not Recruiting Evidence synthesis to assess comparative efficacy of UMEC/VI versus other treatments for COPD adult patients
200170 Recruiting Study 200170: A Rollover Study to Provide Continued Treatment with Eltrombopag
200171 Completed The long-term antibody persistence of GSK Biologicals’ MenACWY-TT vaccine (GSK134612) versus Meningitec or Mencevax ACWY in healthy adolescents and adults and booster response to MenACWY-TT administered 10 years post-primary vaccination
200173 Completed Renal Safety of Adefovir Dipivoxil (ADV) in Chinese Patients with Chronic Hepatitis B
200181 Completed A Randomized Double Blinded (Sponsor Unblind), Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Selective Androgen Receptor Modulator (SARM) in Single and Repeat Doses in Healthy Male Subjects
200182 Not yet recruiting A randomized, double-blind (sponsor unblind), placebo-controlled, multi-centred phase IIa study to evaluate the safety and efficacy of 13 weeks of once daily oral dosing of the selective androgen receptor modulator (SARM) GSK2881078 in older men and post menopausal women with COPD and muscle weakness, participating in home exercise
200185 Completed A Randomized, Double-blind (Sponsor Unblinded), Placebo Controlled, Repeat Dose Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin Study Listed on ClinicalStudyDataRequest.com
200186 Terminated A Randomised, Double-blind (Sponsor Unblind), Placebo-controlled, Two Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects
200187 Completed Epidemiology study of malariometric determinants in selected Post-Approval Programme study sites in sub-Saharan Western Africa
200188 Completed Immunogenicity and safety study of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine (GSK2321138A) Fluarix/Influsplit Tetra® (2013/2014 season) in adults 18 years of age and older
200190 Completed Immunogenicity and safety study of GSK Biologicals’ Trivalent Split Virion Influenza Vaccine (GSK1536489A) Fluviral™ (2013-2014 Season) in adults aged 18 years and older

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.